SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-110222
Filing Date
2007-05-10
Accepted
2007-05-10 16:11:22
Documents
12
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 541447
2 LICENSE AGREEMENT dex101.htm EX-10.1 338792
3 SUPPLY AGREEMENT dex102.htm EX-10.2 169994
4 TRADEMARK LICENSE AGREEMENT dex103.htm EX-10.3 35015
5 SIDE LETTER dex104.htm EX-10.4 24077
6 AMENDED AND RESTATED DIRECTORS COMPENSATION POLICY dex105.htm EX-10.5 19394
7 FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT dex106.htm EX-10.6 38942
8 FORM OF DIRECTOR'S NONQUALIFIED STOCK OPTION GRANT AGREEMENT dex107.htm EX-10.7 39863
9 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9690
10 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9694
11 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3991
12 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3994
  Complete submission text file 0001193125-07-110222.txt   1236285
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-31577 | Film No.: 07837908
SIC: 2834 Pharmaceutical Preparations